|
2023
|
Invention
|
Method for culturing natural killer cells using t cells.
The present invention relates to a meth... |
|
2022
|
Invention
|
5'-utr with improved translation efficiency, a synthetic nucleic acid molecule including the same... |
|
|
Invention
|
Anti-cd3 antibody and pharmaceutical composition for cancer treatment comprising same.
An anti-C... |
|
2021
|
Invention
|
Coronavirus spike protein-specific antibody and use thereof.
Provided are a coronavirus spike (S... |
|
|
Invention
|
Antibody specific to coronavirus spike protein and use thereof. The present invention relates to ... |
|
|
Invention
|
Anti-rsv antibody and pharmaceutical composition comprising same.
The present invention relates ... |
|
|
Invention
|
Anti-rsv antibody and pharmaceutical composition comprising same. The present invention relates t... |
|
|
Invention
|
Method for culturing natural killer cells using t cells. The present invention relates to a metho... |
|
2020
|
Invention
|
Antibody to tigit and use thereof.
The present invention relates to: an antibody to T cell Immun... |
|
|
Invention
|
Antibody to tigit and use thereof. The present invention relates to: an antibody to T cell Immuno... |
|
|
Invention
|
Bispecific antibody specifically binding to gpnmb and cd3, and use thereof. A bispecific anti-GPN... |
|
|
Invention
|
Bispecific antibody specifically binding to gpnmb and cd3, and use thereof. The present invention... |
|
2019
|
Invention
|
Fusion protein comprising anti-mesothelin antibody, anti-cd3 antibody or anti-egfr antibody, bisp... |
|
|
Invention
|
Steric epitope of ceacam1, and anti-ceacam1 antibody, or fragment thereof, that specifically bind... |
|
|
Invention
|
Fusion protein comprising ids and use thereof. An asymmetric fusion protein in which a fragment o... |
|
|
Invention
|
Fusion protein comprising ids and use thereof. The present invention relates to an asymmetric fus... |
|
|
Invention
|
Antibody library and antibody screening method using same. The present invention relates to a nov... |
|
|
Invention
|
Antigen variant of varicella zoster virus and use thereof. An antigen variant and a use thereof a... |
|
|
Invention
|
Antigen variant of varicella zoster virus and use thereof. The present invention relates to an an... |
|
|
Invention
|
In-vivo release sustained recombinant coagulation factor viii and preparation method therefor.
A... |
|
|
Invention
|
In-vivo release sustained recombinant coagulation factor viii and preparation method therefor. in... |
|
2018
|
Invention
|
Protein conjugate and fusion protein which comprise albumin and lysosomal enzyme. in vivoin vivo ... |
|
|
Invention
|
Transformed human cell and use thereof.
The present invention relates to a transformed human cel... |
|
|
Invention
|
Transformed human cell and use thereof. The present invention relates to a transformed huma... |
|
|
Invention
|
Transformed human cell and use thereof. in vivoin vivoin vivo immune response. Therefore, it is e... |
|
|
Invention
|
Anti-cd3 antibody and pharmaceutical composition for cancer treatment comprising same. The presen... |
|
|
Invention
|
Anti-msln antibody and pharmaceutical composition for cancer treatment comprising same. The prese... |
|
|
Invention
|
Factor viii or factor ix gene knockout rabbit, method for preparing same and use thereof.
The pr... |
|
|
Invention
|
Anti-ceacam1 antibody and use thereof. The present invention provides anti-CEACAM1 antibodies wit... |
|
2017
|
Invention
|
Method for measuring immunogenicity of protein agent.
A method for determining immunogenicity of... |
|
|
Invention
|
Recombinant single-chain fviii and chemical conjugate thereof.
The present application provides ... |
|
|
Invention
|
Chimera protein comprising fviii and vwf factors, and use thereof. A chimera protein according to... |
|
|
Invention
|
Ab6 family designer ligands of tgf-β superfamily. A non-naturally occurring chimeric polypeptide ... |
|
|
Invention
|
Composition comprising an ab6 family designer ligand of tgf-beta superfamily for treating liver d... |
|
|
Invention
|
Composition comprising an ab6 family designer ligand of tgf-beta superfamily for treating bone an... |
|
2016
|
Invention
|
Pharmaceutical composition for inhibiting metastasis of cancer, comprising, as active ingredient,... |
